TY  - GEN
AU  - Pilon,Dominic
AU  - Queener,Marykay
AU  - Lefebvre,Patrick
AU  - Ellis,Lorie A
TI  - Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer
SN  - 1941-837X
PY  - 2017///0626
KW  - Abiraterone Acetate
KW  - economics
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - Benzamides
KW  - Clinical Trials, Phase III as Topic
KW  - Costs and Cost Analysis
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Nitriles
KW  - Phenylthiohydantoin
KW  - analogs & derivatives
KW  - Prednisone
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms, Castration-Resistant
KW  - drug therapy
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.3111/13696998.2016.1173042
ER  -